Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
0.386
-0.014 (-3.48%)
Dec 3, 2024, 1:53 PM EST - Market open
Cognition Therapeutics Market Cap
Cognition Therapeutics has a market cap or net worth of $16.07 million as of December 3, 2024. Its market cap has decreased by -49.67% in one year.
Market Cap
16.07M
Enterprise Value
-4.81M
1-Year Change
-49.67%
Ranking
Category
Stock Price
$0.39
Market Cap Chart
Since the IPO on October 8, 2021, Cognition Therapeutics's market cap has decreased from $256.46M to $16.07M, a decrease of -93.73%. That is a compound annual growth rate of -58.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 29, 2024 | 16.70M | -71.89% |
| Dec 29, 2023 | 59.43M | -2.39% |
| Dec 30, 2022 | 60.88M | -56.29% |
| Dec 31, 2021 | 139.27M | -45.69% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tenax Therapeutics | 18.27M |
| Lifeward | 18.23M |
| Marinus Pharmaceuticals | 17.91M |
| BioXcel Therapeutics | 17.47M |
| Cosmos Health | 16.79M |
| Cara Therapeutics | 16.68M |
| Synlogic | 16.55M |
| Microbot Medical | 16.50M |